References
- Anon. (2002). Bulletin Epidemiologique Hebdomadaire, 24, 111–117.
- Croft, A. J. & Garner, P. (1997). British Medical Journal, 315, 1412–1416.
- Croft, A. J. & World, M. J. (1996). Lancet, 347, 326.
- Looareesuwan, S., White, N. J., Warrell, D. A., Forgo, I., Dubach, U. G., Ranalder, U. B. & Schwartz, D. E. (1987). British Journal of Clinical Pharmacology, 24, 37–42.
- Overbosch, D., Schilthius, H., Bienzle, U., Behrens, R. H., Kain, K. C., Clarke, P. D., Toovey, S., Knobloch, J., Nothdurft, H. D., Shaw, D., Roskell, N. S. & Chulay, J. D. (2001). Clinical Infectious Disease, 33, 1015–1021.
- Schlagenhauf, P., Tschopp, A., Johnson, R., Nothdurft, H. D., Beck, B., Schwartz, E., Herold, M., Krebs, B., Veit, O., Allwinn, R. & Steffen, R. (2003). British Medical Journal, 327, 1078–1081.